A critical evaluation of technological innovations in the treatment of symptomatic benign prostatic hyperplasia

British Journal of Urology

Volumn 81, Issue SUPPL. 1, 1998, Pages 56-63

  Fitzpatrick, J M ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; HYPERTHERMIC THERAPY; LASER COAGULATION; LASER SURGERY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; REVIEW;

CATHETER ABLATION; ELECTROCOAGULATION; HUMANS; HYPERTHERMIA, INDUCED; LASER COAGULATION; MALE; PROSTATECTOMY; PROSTATIC HYPERPLASIA; ULTRASONIC THERAPY;

EID: 0031857637     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1998.0810s1056.x     Document Type: Article

References (57)

1. Roos NP, Wennberg JE, Malenka DJ et al Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 1989; 320: 1120-4
2. Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 1989; 141: 243-7
3. Fabian KM. Der intraprostatische spinacle 'Partielle Katheter' (Urologische spiral). Urologe A 1980; 12: 236-8
4. Nordling J, Oveson H, Poulsen AL. The intraprostatic spinal: clinical results in 150 consecutive patients. J Urol 1992; 147: 645-7
5. Chappie CR. Milroy EJ, Rickards D. Permanently implanted urethral stent for prostatic obstruction in the unfit patient: preliminary report. Er J Urol 1990; 66: 58-65
6. Yerushalmi A, Fishelovitz Y, Singer D et al. Localised deep microwave hyperthermia in the treatment of poor operative risk patients with benign prostatic hyperplasia J Urol 1985; 133: 873-6
7. Yerushalmi A, Singer D, Katsnelson R et al. Localised deep microwave hyperthermia in the treatment of benign prostatic hyperplasia: long-term assessment Br J Urol 1992; 70: 178-82
8. Linder A, Braf Z. Colomb J et ai. Local hyperthermia of the prostate gland for the treatment of benign prostatic hypertrophy and urinary retention. Br J Urol 1990; 65: 201-3
9. Fabricius PG, Schaefer J, Schmeller N et al. Efficacy of transrectal hyperthermia for benign prostatic hyperplasia: a placebo controlled study. J Urol 1991; 145: 363A
10. Montorsi F, Galli L, Guazzoni G et al. Transrectal microwave hyperthermia for benign prostatic hyperplasia: long-term clinical, pathological and ultrastructural patterns. J Urol 1992; 148: 321-5
11. Abbou CC, Colombel M, Payan C et al. Transrectal and transurethral hyperthermia vs. sham to treat benign prostatic hyperplasia: a double blind randomized multicentre study. J Urol 1994; 151: 761A
12. Devonec M, Berger N, Perrin P. Transurethral microwave heating of the prostate from hyperthermia to thermotherapy. J Endourol 1991; 5: 129-35
13. Carter S, St C, Ogden C. Intraprostatic temperature vs. clinical outcome in TUMT. Is the response heat-dose dependant. J Urol 1994; 151: 416A
14. Devonec MA. Transurethral thermotherapy. In Kirby R, Me Connell JD, Fitzpatrick JM, Roehrborn CG, Boyle P, eds, Textbook of Benign Prostatic Hyperplasia. Oxford: ISIS Medical Media. 1996: 413-21
15. De la Rosette JJMCH. D'Ancona FCH. Debruyne FMJ. Current status of thermotherapy of the prostate. J Urol 1997: 157: 430-8
16. De la Rosette JJMCH, Froehling FMJA, Debruyne FMJ. Clinical results with microwave thermotherpy of benign prostatic hyperplasia. Eur Urol 1993; 23 (Suppl 1): 68
17. Ogden C, Reddy P, Johnson H et al. Sham vs. transurethral microwave thermotherapy in patients with symptoms of benign prostatic outflow obstruction. Lancet 1993; 341: 14-7
18. Tubaro A. Paradiso Galatioto G, Trucchi A et al. Transurethral microwave thermotherapy in the treatment of symptomatic benign prostatic hyperplasia. Eur Urol 1993; 23: 285
19. Devonec M, Tomera K, Perrrin P. Transurethral microwave thermotherapy in benign prostatic hyperplasia. J Endourol 1993; 7: 255
20. Terai A, Arai Y, Onishi H, Oishi K, Takeuchi H, Yoshida 0. Transurethral microwave thermotherapy for benign prostatic hyperplasia: Clinical results after a 1-year follow-up. M J Urol 1995; 2: 24
21. Blute ML, Tomera K. Hellerstein DK et al. Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: results of the United States Prostatron cooperative study. J Urol 1993; 150: 1591-6
22. Hoefner K, Krah H, Kuczyk M, Tan HK, Jonas U. Changes in outflow obstruction following transurethral microwave thermotherapy. In Marberger M, éd. Application of Newer Forms of Therapeutic Energy in Urology. Oxford: ISIS Medical Media 1995: 41-9
23. Kirby RS, Williams G, Witherow R, Milroy EJG, Philp T. The Prostatron transurethral microwave device in the treatment of bladder outflow obstruction due to benign prostatic hyperplasia. Br J Urol 1993; 72: 190-4
24. Dahlstrand C, Waiden M, Geirsson G, Pettersson S. Transurethral microwave therapy vs. transurethral resection for symptomatic benign prostatic obstruction: a prospective randomized study with a 2-year follow-up. Br J Urol 1995; 76: 614-8
25. 5 Mulvin D, Creagh T, Kelly D, Smith J, Quinlan D, Fitzpatrick J. Transurethral microwave therapy vs. transurethral catheter therapy for benign prostatic hyperplasia. Eur Urol 1994; 26: 6-9
26. De Wildt MJAM, De la Rosette JJMCH. Transurethral microwave thermotherapy: an evolving technology in the treatment of benign prostatic enlargement. Br J Urol 1995; 76: 531-8
27. Nawrocki JD, Bell TJ, Lawrence WT, Ward JPA. randomised controlled trial of transurethral microwave thermotherapy. Br J Urol 1997; 79: 389-93
28. Ahmed M, Bell T, Lawrence WT. Ward JP. Watson GM. Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomised, controlled, parallel study. Br J Urol 1997: 79: 181-5
29. Rasor JS. Zlotta AR, Edwards SD. Schulman CC. Transurethral needle ablation: gradient mapping and comparison of lesion size in a tissue model and in patients with benign prostatic hyperplasia. Eur Urol 1993; 24: 411-4
30. Schulman CC, Zlotta AR, Rasor SR et al Transurethral needle ablation (TUNA): safety, feasibility and tolerance of a new office procedure for treatment of benign prostatic hyperplasia. Eur Urol 1993: 24: 415-23
31. Schulman CC, Zlotta AR. Early clinical experience with a new procedure for treatment of BPH (TUNA). Urology 1995; 45: 28-33
32. Ramon J. Lynch TH. Eardley I et al. Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia: a collaborative multicentre study. Br J Urol 1997; 80: 128-35
33. Wiklund P. Ekman P. Fitzpatrick J et al. Urodymnamic assessment in benign prostatic hyperplasia patients treated by transurethral needle ablation of the prostate (TUNA). Eur Urol 1996: 30 (Supp2): 169
34. Campo B, Bergamaschi F, Ordesi G, Torelli T, Corrado P. TUNA in BPH patients: urodynamic results at 2 years of follow-up. Eur Urol 1996; 30 (Supp 2): 169
35. Oesterling JE, Issa M, Roehrborn CG et al. A single-blind prospective, randomized clinical trial comparing transurethral needle ablation (TUNA) to transurethral resection of the prostate (TURP) for the treatment of benign prostatic hyperplasia (BPH). Eur Urol 1996; 30 (Supp 2): 169
36. Gelet A, Chapelon JY. Margonari J et al. Prostatic tissue destruction by high intensity focused ultrasound: experimentation in canine prostate. J Endourol 1993; 7: 249-53
37. Susani M, Madersbacher S. Kratzik C et al. Morphology of tissue destruction induced by focused ultrasound. Eur Urol 1993: 23: 34-8
38. Ter Haar G. Focused ultrasound therapy. Curr Opin Urol 1994; 4: 89-92
39. Bihrle R, Foster RS, Sanghvi NT et al. High intensity focused ultrasound for the treatment of benign prostatic hyperplasia: early United States clinical experience. J Urol 1994; 151: 1271-5
40. Madersbacher S, Kratzik C, Susani M. Marberger M. Tissue ablation in benign prostatic hyperplasia with high intensity focused ultrasound. J Urol 1994; 152: 1956-61
41. Ebert T, Miller S, Schmitz-Draegee B, Ackermann R. High intensity focused ultrasound (HIFU) in patients with benign prostatic hyperplasia. J Urol 1994; 151: 399A
42. Sullivan LD, Me Loughlin MG, Goldenberg LG, Cleave ME, Marich KW. Early experience with high-intensity focused ultrasound for the treatment of benign prostatic hypertrophy. Br J Urol 1997; 79: 172-6
43. Mulligan ED, Lynch TH. Mulvin D, Greene D. Smith JM, Fitzpatrick JM. High-intensity focused ultrasound in the treatment of benign prostatic hyperplasia. Br J Urol 1997; 79: 177-80
44. Babayan RK. Roth RA. McCullough DL et al. TULIP® Two year results. J Urol 1994; 151: 228A
45. Costello AJ, Johnson DE. Bolton DM. Nd:YAG laser ablation of the prostate as a treatment for benign prostatic hypertrophy. Lasers Surg Med 1992; 12: 121-4
46. Buckley JF, Ligam V. Paterson P el al. Endoscopie laser ablation of the prostate gland (ELAP) J Urol 1994; 151: 229A
47. Cowles RS, Kabalin JN. Childs S et al. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Urology 1995: 46: 155-60
48. Keoghane S. Cranston D. Lawrence K. Doll H. Fellows G. Smith J. The Oxford laser prostate trial: a prospective randomized controlled trial of contact vaporisation of the prostate vs. TURP. J Urol 1995: 153: 230A
49. Narayan P, Tewari A. Fournier G et al. Impact of prostate size and techniques of laser prostatectomy (evaporation vs. coagulation) on the outcome of therpy for benign prostatic hyperplasia. J Urol 1995: 153: 231A
50. McNicholas T, Alsudani M. Akbar VI. Interstitial laser coagulation (ILC) of the prostate: immediate effects and clinical results in man. Eur Urol 1996; 30 (Supp2): 112
51. Muschter R. Hofstetter A. Anson K. Perlmutter A. Vaughan D. Nd:YAG and diode lasers for interstitial laser coagulation of benign prostatic hyperplasia: experimental and clinical evaluation. J Urol 1995; 153: 229A
52. Orovan WL. Whelan JP. Neodymium YAG laser treatment of BPH using interstitial thermometry: A transurethral approach. J Urol 1994; 151: 230A
53. Alsudani M. Hanbury D. Shah T el al. Comparison of techniques and results using three different types of laser delivery to the prostate. Eur Urol 1996; 30 (Supp 2): 219
54. Kaplan S. Laor E, Te A. Transurethral resection of the prostate (TURP) vs. electrovaporisation of the prostate (VAP): a prospective, blinded comparative study of the treatment of benign prostatic hyperplasia. Eur Urol 1996; 30 (Supp 2): 116
55. Gallucci M, Puppo P. Perachino M el al. Transurethral electrovaporisation of the prostate (TVP) vs. TURP. A multicentre randomized comparative study. Eur Urol 1996; 30 (Supp 2): 116
56. Patel G. Fuchs GJ, Gutierrez-Aceves. A. Ryan TP. Prostate heating patterns comparing electrosurgical transurethral resection and vaporization: prospective randomized study. J Urol 1997: 157: 169-72
57. Thomas KJ. Cornaby AJ. Hammadeh M, Philp T. Matthews PN. Transurethral vaporisation of the prostate: a promising new technique. Br JUrol 1997; 79: 186-9